- Issuer ticker
-
ENTX
- Reported as of
-
14 Nov 2024
- Net transaction value
-
$0
Source evidence
Original filing metadata and source links for verification.
3 source fields
- SEC form
-
3
- Accepted by SEC
-
20 Nov 2024, 13:53:33 UTC
Reporting owner
1 detail
- Reporting owner signature
-
/s/ Fred Knoll
Key filing fact
Knoll Capital Management, LLC filed Form 3 for Entera Bio Ltd. (ENTX) on 20 Nov 2024.
Key facts
- This page summarizes Knoll Capital Management, LLC's Form 3 filing for Entera Bio Ltd. (ENTX).
- 0 reported transactions and 2 derivative rows are listed below.
- Accepted by SEC: 20 Nov 2024, 13:53.
Change
- No earlier filing in this sequence is available for direct comparison.
- Current net transaction value: $0.
Research use
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Evidence
Official SEC source
Ownership activity is grounded in SEC Form 3 disclosures.
View source filing
Reported non-derivative transactions
Shares, units, or other non-derivative securities reported in this filing.
ENTX
holding
Ordinary Shares, par value NIS 0.0000769 per share
No transaction description listed
- Transaction value
- Shares
- Change %
- Price
-
- Shares after
- 5,534,275
- Date
- 14 Nov 2024
- Ownership
- Direct
Reported derivative securities
Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.
ENTX
holding
Derivative
Pre-funded warrant
No transaction description listed
- Transaction value
- Shares
- Change %
- Price
-
- Shares after
- Date
- 14 Nov 2024
- Ownership
- Direct
- Underlying class
- Ordinary Shares, par value NIS 0.0000769 per share
- Underlying amount
- 347,604
- Exercise price
- $0.000000
ENTX
holding
Derivative
Warrants (right to buy)
No transaction description listed
- Transaction value
- Shares
- Change %
- Price
-
- Shares after
- Date
- 14 Nov 2024
- Ownership
- Direct
- Underlying class
- Ordinary Shares, par value NIS 0.0000769 per share
- Underlying amount
- 1,197,604
- Exercise price
- $1.00
* marks a reported price that did not pass the local price check.
SEC remarks
* Gakasa beneficially owns 5,534,275 Shares of the Issuer's Common Stock and 347,604 pre-funded warrants. Each of KCM and Knoll beneficially own 5,534,275 Shares of the Issuer's Common Stock and 347,604 pre-funded warrants. KCM has trading authority for Gakasa, and Knoll is the President of KCM. KCM is a limited liability company formed and existing under the laws of the State of Florida. Knoll is a citizen of the United States. Gakasa is a limited liability company organized under the laws of the State of Florida.